Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis
Launched by KEPLER UNIVERSITY HOSPITAL · Jul 4, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the impact of two different surgical approaches on the quality of life for patients with left-sided diverticulitis, which is a condition where small pouches in the colon become inflamed. The trial will include adults aged 65 and older who have been diagnosed with acute complicated diverticulitis or recurrent diverticulitis without complications. Participants will be randomly assigned to one of two groups: one group will have surgery within 7 to 10 days after being admitted to the hospital, while the other group will have surgery 6 to 8 weeks after their initial treatment.
Participants can expect to answer questions about their quality of life before and after their surgeries using simple scoring systems. This will help researchers understand how each surgical approach affects recovery and overall well-being. To join the study, individuals must provide informed consent and meet specific health criteria, such as not being pregnant and not having certain other medical conditions. This trial is currently recruiting participants, and it aims to improve treatment options for those suffering from diverticulitis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consent to participate in the study
- • CDD Type 2a, 2b: acute complicated left-sided diverticulitis
- • CDD Type 3b: relapsing diverticulitis without complications (\>2 episodes within 2 years)
- • Acute presentation
- • Inflammation located in the left-sided colon
- • Inflammation is CT proven or ultrasound confirmed from experienced radiologists
- Exclusion Criteria:
- • \< 18 years
- • Pregnancy
- • BMI \> 55kg/m2
- • Current colorectal carcinoma in the left-sided colon
- • Oral and/or intravenous corticosteroid
- • Ongoing chemotherapy
- • Status post left hemicolectomy
- • Patients who cannot take care of themselves at home or are unable to follow instructions
- • Patients who are not fit for surgery (anesthesia, expert knowledge from specialists) and will not benefit from surgery
About Kepler University Hospital
Kepler University Hospital is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital collaborates with multidisciplinary teams to conduct rigorous studies that aim to enhance treatment methodologies and improve patient outcomes. Leveraging its state-of-the-art facilities and commitment to excellence, Kepler University Hospital plays a pivotal role in translating scientific discoveries into practical applications, thereby contributing to the advancement of medical knowledge and the improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mannheim, , Germany
Linz, Upper Austria, Austria
Linz, Upper Austria, Austria
Linz, , Austria
Patients applied
Trial Officials
Andreas Shamiyeh, Dr.
Principal Investigator
Kepler University Hospital Linz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported